Kimberly A. Reed
CIK: 0001873931
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)3 (33.3%)
Derivative conversions
Awards (A)5 (55.6%)
Compensation grants
Other (G, F, J, C, D, …)1 (11.1%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History
About Reed Kimberly A.
Reed Kimberly A. (SEC CIK 0001873931) files insider reports with the SEC as Director of TAKEDA PHARMACEUTICAL CO LTD (TAK), Director of HA Sustainable Infrastructure Capital, Inc. (HASI) and Director of Momentus Inc. (MNTS).
Signal8 holds 7 ownership filings by Reed Kimberly A. (1 Form 3, 6 Form 4), filed between Nov 5, 2024 and Jul 6, 2026. Those filings report 9 transactions, from Nov 1, 2024 to Jul 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Reed Kimberly A.'s filings is in SANTA CLARA, CA.
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pacheco Rhonda Janice, President, U.S. Business Unit